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OVERVIEW
One Health is an increasingly popular approach used to tackle 
complex health problems. The One Health concept recog-
nizes that human health is tightly connected to the health 
of animals and the environment. Although the related fields 
are now more aware of the benefits of collaborative working, 
the full benefits have not yet been realized as research efforts 
are often focussed on just one of these health domains. To 
address regional and global issues such as foodborne zoon-
oses (FBZ), antimicrobial resistance (AMR) and emerging 
infectious threats (ET), there must be transdisciplinary 
collaboration between the health domains, in addition to 
active dialogue between scientists and international policy 
makers. This editorial introduces the One Health European 
Joint Programme (OHEJP) as an example of a One Health 
initiative.
Zoonoses, AMR and their global burden
Zoonoses are infectious diseases that can be transmitted 
directly or indirectly between humans and animals. Although 
the severity of zoonotic infections varies, their global 
impact is undisputable. The World Bank estimates that just 
six zoonotic disease outbreaks between 1997 and 2009 led 
to a global economic loss of US$ 80 billion [1]. This high 
cost is due to medical costs, loss of individual productivity 
and restrictions on trade and movement during outbreaks. 
Despite improvements in the management and treatment of 
zoonotic outbreaks, high disease burdens caused by zoonotic 
pathogens continue to be reported globally. These problems 
have been amply demonstrated recently by the SARS- CoV-2 
pandemic. Although it is still too soon to fully assess the total 
economic and societal cost of this virus, recent publications, 
such as Nicola et al. [2] have begun to highlight just how 
widespread the impact of a truly global zoonotic disease can 
be.
Alongside zoonoses, AMR is a growing international issue. 
The World Health Organization (WHO) has listed AMR as 
one of the ten greatest global health threats in 2019 [3]. AMR 
is defined as the ability of microorganisms to survive the effect 
of antimicrobial drugs, hindering not only our ability to treat 
infectious diseases, but also to perform medical procedures 
requiring prophylactic antibiotic administration. It has been 
predicted that by 2050, the number of deaths due to unrespon-
sive infections will reach 10 million annually, with the associ-
ated costs being estimated at US$ 100 trillion [4]. Increased 
and inappropriate use of antimicrobials has contributed to the 
development and spread of AMR, which can be transmitted 
between humans, animals and the environment.
The history of the ‘One Health’ concept
The origins of One Health go as far back as 1855, when Rudolf 
Virchow founded comparative pathology, which could be seen 
as the origin of the One Health concept. Building upon this, 
Calvin W. Schwabe argued in the twentieth century against 
compartmentalization in medical research, using the term 
‘One Medicine’. The term One Health was then popularized in 
2004 by the Wildlife Conservation Society at a conference in 
New York [5], and its use has continued to evolve since then, 
fostering the revival of comparative medicine (Fig. 1, and 
reviewed in Gibbs [6]). One Health has now been adopted by 
the WHO [7], the Food and Agriculture Organization (FAO) 
[8] and the World Organization for Animal Health (OIE) [9].
The importance of collaborative One Health 
projects
The use of a coordinated One Health approach has successfully 
tackled some zoonotic infections, although typically success 
is observed where problems are geographically restricted 
and controlled by a single governmental unit. One successful 
example involving multiple governments is the reduction in 
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human Salmonella infections within the UK during the early 
1990s. The infection was linked to the consumption of poultry 
products, in particular eggs [10]. Coordination between 
multiple government agencies and research agencies with 
expertise in human, animal and environmental health led 
to improved biosecurity on farms, surveillance, vaccination 
programmes for laying hens, and public health programmes 
[10]. This resulted in a nationwide food- safety scheme, the 
Lion Brand, which was introduced to highlight which eggs 
have been produced under the specified standards of food 
safety.
In contrast, AMR is still a global issue requiring One Health 
approaches to work on effective solutions [11]. Veterinar-
ians, medical doctors, dentists, healthcare professionals 
and farmers have a significant role to play, allowing rapid 
detection and intervention at the source to reduce antibiotic 
use, particularly of critically important antibiotics. Despite 
the increasing uptake of the One Health approach to health 
issues, there are still measures to be taken to improve trans-
disciplinary collaboration of One Health research and surveil-
lance to ensure approaches are harmonized for national and 
international benefit.
From research outputs to policy changes
To address these challenges of interdisciplinary coordina-
tion, the five year OHEJP was established in 2018 and boasts 
a landmark partnership between 37 partners across 19 
member states in Europe and the Med- Vet- Net- Association 
(Fig. 2). This programme is an interdisciplinary, collaborative 
and international approach to address One Health issues in 
the fields of FBZ, AMR and ET. Its main focus is to provide 
opportunities for the harmonization of approaches, meth-
odologies, databases and procedures for the assessment and 
management of FBZ, AMR and ET across Europe, which 
will improve the quality and compatibility of information for 
decision making and informing policy change. The OHEJP 
has Joint Research Projects (JRP), Joint Integrative Projects 
(JIP), PhD projects, and it funds Short Term Missions each 
year. These are key instruments to facilitate partner institutes 
working together and aligning their approach, in addition 
to sharing their knowledge and expertise. Furthermore, the 
OHEJP aims to create a global ‘One Health Community’ 
through the research projects, PhD projects, workshops, 
Continuing Professional Development (CPD) modules, 
Summer Schools and Annual Scientific Meetings, which aim 
to attract both those inside and outside of the consortium to 
increase awareness and create opportunities for collaborative 
solutions.
The OHEJP has active dialogue with the key European 
agencies, the European Centre for Disease Prevention and 
Control (ECDC) and the European Food Safety Authority 
(EFSA) to ensure that One Health needs are addressed in 
a synergistic way. This approach aims to improve cross- 
disciplinary collaboration and communication, which in turn 
facilitates the OHEJP’s aim to translate science into policy 
and enables it to tackle FBZ, AMR and ET on a much larger 
scale. The OHEJP has a work package dedicated to translating 
science to policy and communicating with stakeholders, in 
particular with ECDC and EFSA, and international policy 
makers, including WHO, FAO and OIE. This communication 
is essential to identify and discuss research and integrative 
needs, and to ensure that the activities of the OHEJP meet 
Fig. 1. Timeline of selected key One Health milestones since 1855. An increasing uptake of One Health approaches by large agencies is 
evident from 2004 onwards.
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these needs, e.g., by incorporating them into the OHEJP 
Strategic Research Agenda (found on our website at www. 
onehealthejp. eu), ensuring the results and outputs will be 
useful and utilized.
Furthermore, communication and dissemination are key 
components of the OHEJP. Effective communication will 
improve collaboration across sectors and the overall aware-
ness of the general public, in addition to policy makers at all 
levels. The OHEJP aims to improve awareness of key issues 
through events, which attract audiences from across the globe, 
a website and social media networks. In summary, a glob-
ally coordinated approach is required, between the medical, 
veterinary and environmental professions to tackle emerging 
One Health issues, ultimately improving food security and 
human and animal health.
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